Brazil
Gênica, founded in 2015 by agronomist Fernando Reis with support from technical expert Prof. Dr. Carlos Labate of ESALQ-USP, is a pioneering company in the field of bioinputs, aiming to "Cultivate value for generations". It is dedicated to crafting substantial impacts within the agribusiness sphere through its commitment to innovation, excellence, and results.
The company gained notable momentum in 2017 when SP Ventures, known for investing in high-potential, disruptive startups, came aboard as an investor. This collaboration significantly benefited Gênica by infusing market insights and innovative expertise into its operations.
In 2020, another strategic partnership was formed with Nitro Química, a firm recognized for its robust financial framework and strong corporate governance. This alliance enabled substantial business expansion, enhancing sales and marketing capabilities, R&D investments, and manufacturing capacity.
Headquartered in Brazil, Gênica operates at the intersection of Agriculture, Biotechnology, and AgriTech. As of 01 July 2024, the company secured a BRL68.00M Venture Round investment, backed by Banco do Brasil and Agrex, underscoring its ongoing growth trajectory and attractiveness to investors.
